Cytotoxic effects of tea (Camellia sinensis), stevia (Stevia rebaudiana), moringa (Moringa oleifera) leaves, and their potential as functional beverages for cancer patients
DOI:
https://doi.org/10.31989/bchd.v8i8.1690Περίληψη
The global incidence of cancer has been rising annually, affecting various types and increasing the number of patients. Research on cancer, including its pathology, treatment, and management of side effects, continues to evolve, yet no truly satisfactory outcomes have been achieved. Pharmacological cancer therapy should be complemented with non-pharmacological approaches to improve the quality of life of cancer patients. Chemotherapy-induced nausea and vomiting (CINV) still troubles patients after all these years, making functional beverages a potential target to overcome this problem. Several natural ingredients, including tea, moringa, and stevia leaves, have been empirically used as functional beverages due to their antioxidant level. Therefore, it's necessary to determine whether these plants exhibit cytotoxic effects on cancer cells and their interaction with anticancer drugs. This review aimed to compile previous research on the potential of tea, moringa, and stevia leaves as functional beverages for cancer patients. Their cytotoxic effect has been demonstrated in several in vitro studies, with no reported metabolic herbal-drug interactions.
Novelty: This review highlights the underexplored potential of tea, stevia, and moringa as functional beverage components with cytotoxic properties relevant to cancer patient care.
Keywords: cancer, functional food, tea, stevia, moringa
Δημοσιευμένα
Τεύχος
Ενότητα
Άδεια
Πνευματική ιδιοκτησία (c) 2025 FFC/Bioactive Compounds in Health and Disease
Αυτή η εργασία είναι αδειοδοτημένη υπό το CC Αναφορά Δημιουργού – Μη Εμπορική Χρήση 4.0.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.